Tuesday, December 14, 2021

Wednesday's News Links

[Yahoo/Bloomberg] U.S. Stocks Steady as Fed Decision Looms: Markets Wrap

[Yahoo/Bloomberg] Oil Falls Further on Looming Surplus, China Demand Constraints

[Reuters] Fed prepares to stiffen inflation response for a post-transitory world

[Yahoo/Bloomberg] New Era of Bond-Market Volatility Begins as Fed Fights Inflation

[Yahoo/Bloomberg] U.S. Retail Sales Trail Forecast, Suggesting Drag From Inflation

[CNBC] Mortgage refinances fizzle as interest rates resume their climb

[Yahoo/Bloomberg] Omicron to Become Dominant EU Strain; J&J Booster: Virus Update

[Yahoo/Bloomberg] Princeton, Cornell Move Finals Online as Omicron Is Detected

[AP] EU official: Omicron to be dominant variant by mid-January

[Yahoo/Bloomberg] Crash in Shimao Bonds Stokes Contagion Fear, Bailout Speculation

[Yahoo/Bloomberg] China Home Market Slump Persists as Prices, Sales Fall

[Reuters] 'Under pressure': China property market hit by more headwinds

[Yahoo/Bloomberg] One More Developer Seeks to Extend Debt Due: Evergrande Update

[AP] China economy slows as virus outbreaks disrupt recovery

[CNBC] China’s retail sales grow by 3.9% in November — slower than expected

[Reuters] Chinese banks to see doubling of bad property loan ratio, warns S&P

[Yahoo/Bloomberg] U.S. to Blacklist DJI and Seven Other China Firms, FT Reports

[Reuters] UK inflation jumps above 5% as BoE considers rate rise

[Reuters] Putin and Xi cement partnership in face of Western pressure

[Reuters] Xi says China, Russia should safeguard each other's security interests

[Bloomberg] China’s Economy Slows in November as Property Slump Deepens

[Bloomberg] Omicron Infects 70 Times Faster But Is Less Severe, Study Says

[NYT] The Fed Meets Amid Faster Inflation and Prepares to React

[WSJ] China’s Economic Activity Slowed in November on Property Slump, Weak Consumption

[FT] Fed poised to announce acceleration of stimulus taper

[FT] China struggles to shrug off weak consumer spending and property woes

[FT] US ‘exposed’ as it braces for Omicron challenge

[FT] China’s Sinovac offers inadequate protection against Omicron, study shows